8.Andre T, Boni C, Mounedji-Boudiaf L,et al.Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.N Engl J Med 2004; 350:2343-2351. 9.Andre T, Boni C, Navarro M, et al.Improved overall survival with oxaliplatin, fluorourac...
One of the newest and most potent chemotherapies for colon cancer is as safe and effective for the elderly as it is for younger patients, based on a University of North Carolina at Chapel Hill-led data review.doi:10.4161/cbt.5.3.2595...
The FOLFOX regimen, a combination of oxaliplatin, leucovorin, and 5-fluorouracil (5-FU), has been the standard of care since the MOSAIC trial (Multicenter International Study of Oxaliplatin/5FU-LV in the Adjuvant Treatment of Colon Cancer) reported its results (Cancer Treat. Rev. 2004;30:711...
14、orin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancerJ.J Clin Oncol,2000,18(16):2938一2947.4. Andre T, Boni C, Mounedji2Boudiaf L, et al. Oxalip latin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med...
Chemoradiotherapy (CRT) is a valuable treatment option for localized esophageal cancer. Conventional baseline chemotherapy for this type of cancer includes... T Yoshii,H Hara,M Asayama,... - 《Molecular & Clinical Oncology》 被引量: 0发表: 0年 Exosomes secreted from human colon cancer cells in...
Oxalip latin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med, 2004, 350: 2343-2351. 5. Saltz LB, Cox JV, Blanke C, et al. lrinotecan for metastatic colorectal cancer[J] .N Engl J Med, 2000, 343: 905- 914. 6. Douillard JY,Cunningham D,Roth ...
There was no significant difference in the levels of carbohydrate antigen 199 (CA19-9), colon cancer-specific antigen (CCSA-2) and osteopontine (OPN) between the two groups before treatment (all P > 0.05); after treatment, CA19-9, CCSA-2, OPN levels were lower than those before ...
mFOLFOX6scheme,theclinicalcurativeeffectoftreatmentforcoloncancerlivermetastasisisremarkable. Keywords:cetuximab;chemotherapy;colorectalcancer;livemetastases 结直肠癌发现时多为中晚期,失去了手术机会,其中约有 50%的患者发生肝转移,这也是大部分晚期患者的死因 [1] 。据统 计,我国结直肠癌的发病率为15.7/10万,占...
Time to initiation of postoperative chemotherapy: an outcome measure for patients undergoing laparoscopic resection for rectal cancer [J]. Dis Colon Rectum, 2013, 56(8): 945-951. [13] BERTOLINI F, CHIARA S, BENGALA C, et al. Neoadjuvant treatment with single-agent cetuximab followed by 5-...
目的探讨预防FOLFOX4方案化疗结肠癌产生的不良反应的措施。方法对本院20112013年收治的48例晚期结肠癌患者的临床资料进行分析。结果 48例患者出现的毒副反应大多比较轻微,以Ⅰ~Ⅱ度为主,Ⅲ~Ⅳ度少见。骨髓抑制不良反应中,白细胞下降I度者4例,II度者3例,Ⅲ度者1例,Ⅳ度者0例;血小板下降I度者8例,II度者4例...